tirzepatide risk vs. Semaglutide: What You Should Know Tirzepatide Side Effects: Risks, Safety,

(UK) al

The most common side effects reported in the tirzepatide groups were diarrhea and nausea.In patients with type 2 diabetes who had inadequate control of blood sugar levels despite treatment with insulin glargine, adding subcutaneous tirzepatide to titrated insulin glargine led to significant improvements in glycemic control after 40 weeks, along with reductions in body weight

To make this accessible, we do not take insurance

For this reason, they're not regulated or approved by the MHRA in the UK

An SAE is any undesirable medical occurrence associated with a medical outcome that results in death, life-threatening conditions, hospitalization, permanent disability, birth defects, the need for medical intervention to prevent lasting harm, or other serious medical complications requiring urgent care